Respiratory Syncytial Virus (RSV) Vaccine – AREXVY

HKD $2,800

  • The only RSV vaccine registered by the U.S FDA, CDC, and Hong Kong Department of Health
  • Highly effective in preventing RSV-induced lower respiratory tract infections, with a remarkable efficacy of 82.6%
  • Individuals aged 60 and above (especially those with chronic diseases) are advised to consult their doctors to discuss vaccination strategies.